Información del producto
CTLA-4 is a protein that regulates the immune response. The CTLA-4 - inhibitor (CTLA-4I) binds to CTLA-4 and blocks its interaction with immune cells, leading to an increase in the number of T cells. This drug has been shown to be effective against urothelial carcinoma and autoimmune diseases. It also has been used in some cases of angiosarcoma, toxic epidermal necrolysis, renal cell cancer, and other cancers. CTLA-4I is most often used in combination with platinum-based chemotherapy or radiation therapy. There are multicenter phase II clinical trials underway for this drug for use as a treatment for hematopoietic malignancies such as leukemia and lymphoma.
Propiedades químicas
Consulta técnica sobre: 3D-FC137667 CTLA-4 - inhibitor
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
